Stay informed with the latest litigation news. Explore now

Egis competitive analysis

Latest publications and patents of Egis New

Explore the latest publications and patents granted to Egis, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Egis

Jan 8, 2020Compositions Comprising Amlodipine And BisoprololRevoked
May 1, 2019Compositions Comrrising Amlodipine And BisoprololRevoked

Explore patent oppositions filed by Egis against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 18, 2025
New UseNOVARTISJul 8, 2024
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISOct 9, 2023
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISJul 11, 2023
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 31, 2021
Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIMAug 12, 2019

Explore Egis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 8, 2020Compositions Comprising Amlodipine And Bisoprolol1
May 1, 2019Compositions Comrrising Amlodipine And Bisoprolol1

Latest PTAB cases involving Egis New

Discover the latest PTAB cases involving Egis, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 12, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Egis

IPR2022-01472Aug 29, 2022DAYUS REGISTER & GRILLEINVTerminated-Settled
IPR2022-01475Aug 29, 2022DAYUS REGISTER & GRILLEINVTerminated-Settled
IPR2021-01324Aug 12, 2021AMPHASTAR PHARMACEUTICALSAEGIS THERAPEUTICSFinal Written Decision
IPR2021-00876May 19, 2021HISENSEAEGIS 11Terminated-Settled
IPR2021-00903May 6, 2021HISENSEAEGIS 11Terminated-Settled
IPR2021-00829Apr 22, 2021HISENSEAEGIS 11Terminated-Settled
IPR2020-01225Aug 7, 2020APPLEUNIVERSAL SECURE REGISTRYTerminated-Settled
IPR2020-01224Aug 7, 2020APPLEUNIVERSAL SECURE REGISTRYTerminated-Settled
IPR2020-01222Jul 20, 2020APPLEUNIVERSAL SECURE REGISTRYTerminated-Settled
IPR2020-01223Jul 20, 2020APPLEUNIVERSAL SECURE REGISTRYTerminated-Settled

Top competitors of Egis

Top competitors of Egis based on patent oppositions.